Valeo Financial Advisors, LLC Guardant Health, Inc. Transaction History

Valeo Financial Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 22, 2021	SELL	$109.77 - $165.68 $186,828 - $281,987	-1,702 Closed	0 $0
Q1 2021 Apr 12, 2021	BUY	$127.04 - $179.1 $9,528 - $13,432	75 Added 4.61%	1,702 $260,000
Q4 2020 Feb 11, 2021	BUY	$99.96 - $135.93 $162,634 - $221,158	1,627 New	1,627 $210,000
Q1 2020 Apr 13, 2020	SELL	$59.04 - $88.81 $354 - $532	-6 Closed	0 $0
Q3 2019 Oct 15, 2019	BUY	$62.59 - $110.3 $375 - $661	6 New	6 $0
Q2 2019 Jul 10, 2019	SELL	$63.94 - $91.11 $10,869 - $15,488	-170 Closed	0 $0
Q1 2019 Apr 12, 2019	BUY	$34.3 - $97.98 $5,830 - $16,656	170 New	170 $13,000

324

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.59B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Valeo Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Valeo Financial Advisors, LLC with notifications on news.